Differential Connexin Function Enhances Self-Renewal in Glioblastoma

Cell Reports

Volumn 11, Issue 7, 2015, Pages 1031-1042

  Hitomi, Masahiro ^a,b   Deleyrolle, Loic P ^c   Mulkearns Hubert, Erin E ^a   Jarrar, Awad ^a   Li, Meizhang ^a,e   Sinyuk, Maksim ^a   Otvos, Balint ^a   Brunet, Sylvain ^a   Flavahan, William A ^a   Hubert, Christopher G ^a   Goan, Winston ^a   Hale, James S ^a   Alvarado, Alvaro G ^a,b   Zhang, Ao ^a   Rohaus, Mark ^c   Oli, Muna ^c   Vedam Mai, Vinata ^c   Fortin, Jeff M ^c   Futch, Hunter S ^c   Griffith, Benjamin ^c   Wu, Qiulian ^a   Xia, Chun hong ^d   Gong, Xiaohua ^d   Ahluwalia, Manmeet S ^a,b   Rich, Jeremy N ^a,b   Reynolds, Brent A ^c   Lathia, Justin D ^a,b   more..

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d Berkeley   (United States)

^e YUNNAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; CONNEXIN 46; GAP JUNCTION PROTEIN; GJA1 PROTEIN, HUMAN;

ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LEVEL; CELL RENEWAL; CONTROLLED STUDY; GAP JUNCTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMBRANE STEADY POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR GROWTH; TUMOR PROMOTION; ANIMAL; BRAIN TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; MEMBRANE POTENTIAL; METABOLISM; PATCH CLAMP TECHNIQUE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; CELL COMMUNICATION; CONNEXIN 43; CONNEXINS; FLUORESCENT ANTIBODY TECHNIQUE; GAP JUNCTIONS; GLIOBLASTOMA; HETEROGRAFTS; HUMANS; IMMUNOBLOTTING; MEMBRANE POTENTIALS; NEOPLASTIC STEM CELLS; PATCH-CLAMP TECHNIQUES; POLYMERASE CHAIN REACTION;

EID: 84929704512     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.04.021     Document Type: Article

References (56)

1. Banerjee D., Das S., Molina S.A., Madgwick D., Katz M.R., Jena S., Bossmann L.K., Pal D., Takemoto D.J. Investigation of the reciprocal relationship between the expression of two gap junction connexin proteins, connexin46 and connexin43. J.Biol. Chem. 2011, 286:24519-24533.
2. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
3. Beyer E.C., Berthoud V.M. Connexin hemichannels in the lens. Front. Physiol. 2014, 5:20.
4. Cheng A., Tang H., Cai J., Zhu M., Zhang X., Rao M., Mattson M.P. Gap junctional communication is required to maintain mouse cortical neural progenitor cells in a proliferative state. Dev. Biol. 2004, 272:203-216.
5. Cottin S., Gould P.V., Cantin L., Caruso M. Gap junctions in human glioblastomas: implications for suicide gene therapy. Cancer Gene Ther. 2011, 18:674-681.
6. Dbouk H.A., Mroue R.M., El-Sabban M.E., Talhouk R.S. Connexins: a myriad of functions extending beyond assembly of gap junction channels. Cell Commun. Signal. 2009, 7:4.
7. Elfgang C., Eckert R., Lichtenberg-Fraté H., Butterweck A., Traub O., Klein R.A., Hülser D.F., Willecke K. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J.Cell Biol. 1995, 129:805-817.
8. Elias L.A., Wang D.D., Kriegstein A.R. Gap junction adhesion is necessary for radial migration in the neocortex. Nature 2007, 448:901-907.
9. Evans W.H., Martin P.E. Gap junctions: structure and function (Review). Mol. Membr. Biol. 2002, 19:121-136.
10. Eyler C.E., Wu Q., Yan K., MacSwords J.M., Chandler-Militello D., Misuraca K.L., Lathia J.D., Forrester M.T., Lee J., Stamler J.S., et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 2011, 146:53-66.
11. Fonseca P.C., Nihei O.K., Savino W., Spray D.C., Alves L.A. Flow cytometry analysis of gap junction-mediated cell-cell communication: advantages and pitfalls. Cytometry A 2006, 69:487-493.
12. Foss B., Hervig T., Bruserud O. Connexins are active participants of hematopoietic stem cell regulation. Stem Cells Dev. 2009, 18:807-812.
13. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004, 64:7011-7021.
14. Gerido D.A., DeRosa A.M., Richard G., White T.W. Aberrant hemichannel properties of Cx26 mutations causing skin disease and deafness. Am. J. Physiol. Cell Physiol. 2007, 293:C337-C345.
15. Gielen P.R., Aftab Q., Ma N., Chen V.C., Hong X., Lozinsky S., Naus C.C., Sin W.C. Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway. Neuropharmacology 2013, 75:539-548.
16. Gong X., Li E., Klier G., Huang Q., Wu Y., Lei H., Kumar N.M., Horwitz J., Gilula N.B. Disruption of alpha3 connexin gene leads to proteolysis and cataractogenesis in mice. Cell 1997, 91:833-843.
17. Guryanova O.A., Wu Q., Cheng L., Lathia J.D., Huang Z., Yang J., MacSwords J., Eyler C.E., McLendon R.E., Heddleston J.M., et al. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 2011, 19:498-511.
18. Hao J., Zhang C., Zhang A., Wang K., Jia Z., Wang G., Han L., Kang C., Pu P. miR-221/222 is the regulator of Cx43 expression in human glioblastoma cells. Oncol. Rep. 2012, 27:1504-1510.
19. Harris A.L. Emerging issues of connexin channels: biophysics fills the gap. Q.Rev. Biophys. 2001, 34:325-472.
20. Huang R., Lin Y., Wang C.C., Gano J., Lin B., Shi Q., Boynton A., Burke J., Huang R.P. Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res. 2002, 62:2806-2812.
21. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., Steindler D.A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers invitro. Glia 2002, 39:193-206.
22. Jäderstad J., Jäderstad L.M., Li J., Chintawar S., Salto C., Pandolfo M., Ourednik V., Teng Y.D., Sidman R.L., Arenas E., et al. Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host. Proc. Natl. Acad. Sci. USA 2010, 107:5184-5189.
23. Juszczak G.R., Swiergiel A.H. Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:181-198.
24. Kandouz M., Batist G. Gap junctions and connexins as therapeutic targets in cancer. Expert Opin. Ther. Targets 2010, 14:681-692.
25. Lathia J.D., Gallagher J., Heddleston J.M., Wang J., Eyler C.E., Macswords J., Wu Q., Vasanji A., McLendon R.E., Hjelmeland A.B., Rich J.N. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 2010, 6:421-432.
26. Lathia J.D., Li M., Sinyuk M., Alvarado A.G., Flavahan W.A., Stoltz K., Rosager A.M., Hale J., Hitomi M., Gallagher J., et al. High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor. Cell Rep. 2014, 6:117-129.
27. Li Z., Bao S., Wu Q., Wang H., Eyler C., Sathornsumetee S., Shi Q., Cao Y., Lathia J., McLendon R.E., et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009, 15:501-513.
28. Lin G.C., Rurangirwa J.K., Koval M., Steinberg T.H. Gap junctional communication modulates agonist-induced calcium oscillations in transfected HeLa cells. J.Cell Sci. 2004, 117:881-887.
29. Liu G., Yuan X., Zeng Z., Tunici P., Ng H., Abdulkadir I.R., Lu L., Irvin D., Black K.L., Yu J.S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 2006, 5:67.
30. Mackay D., Ionides A., Kibar Z., Rouleau G., Berry V., Moore A., Shiels A., Bhattacharya S. Connexin46 mutations in autosomal dominant congenital cataract. Am. J. Hum. Genet. 1999, 64:1357-1364.
31. Mazzoleni S., Politi L.S., Pala M., Cominelli M., Franzin A., Sergi Sergi L., Falini A., De Palma M., Bulfone A., Poliani P.L., Galli R. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res. 2010, 70:7500-7513.
32. Molina S.A., Takemoto D.J. The role of Connexin 46 promoter in lens and other hypoxic tissues. Commun. Integr. Biol. 2012, 5:114-117.
33. Munoz J.L., Rodriguez-Cruz V., Greco S.J., Ramkissoon S.H., Ligon K.L., Rameshwar P. Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43. Cell Death Dis. 2014, 5:e1145.
34. Nahab F.B., Wittevrongel L., Ippolito D., Toro C., Grimes G.J., Starling J., Potti G., Haubenberger D., Bowen D., Buchwald P., et al. An open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremor. Neurotherapeutics 2011, 8:753-762.
35. Naus C.C., Laird D.W. Implications and challenges of connexin connections to cancer. Nat. Rev. Cancer 2010, 10:435-441.
36. Qu Y., Dahl G. Function of the voltage gate of gap junction channels: selective exclusion of molecules. Proc. Natl. Acad. Sci. USA 2002, 99:697-702.
37. Rozental R., Srinivas M., Spray D.C. How to close a gap junction channel. Efficacies and potencies of uncoupling agents. Methods Mol. Biol. 2001, 154:447-476.
38. Scherer S.S., Kleopa K.A. X-linked Charcot-Marie-Tooth disease. J.Peripher. Nerv. Syst. 2012, 17(Suppl 3):9-13.
39. Shill H.A., Bushara K.O., Mari Z., Reich M., Hallett M. Open-label dose-escalation study of oral 1-octanol in patients with essential tremor. Neurology 2004, 62:2320-2322.
40. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
41. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
42. Soeda A., Park M., Lee D., Mintz A., Androutsellis-Theotokis A., McKay R.D., Engh J., Iwama T., Kunisada T., Kassam A.B., et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 2009, 28:3949-3959.
43. Soroceanu L., Manning T.J., Sontheimer H. Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia 2001, 33:107-117.
44. Stupp R., Hegi M.E., Mason W.P., van den Bent M.J., Taphoorn M.J., Janzer R.C., Ludwin S.K., Allgeier A., Fisher B., Belanger K., et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009, 10:459-466. European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups, National Cancer Institute of Canada Clinical Trials GroupNational Cancer Institute of Canada Clinical Trials Group.
45. Suvà M.L., Rheinbay E., Gillespie S.M., Patel A.P., Wakimoto H., Rabkin S.D., Riggi N., Chi A.S., Cahill D.P., Nahed B.V., et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 2014, 157:580-594.
46. Tazuke S.I., Schulz C., Gilboa L., Fogarty M., Mahowald A.P., Guichet A., Ephrussi A., Wood C.G., Lehmann R., Fuller M.T. A germline-specific gap junction protein required for survival of differentiating early germ cells. Development 2002, 129:2529-2539.
47. Todorova M.G., Soria B., Quesada I. Gap junctional intercellular communication is required to maintain embryonic stem cells in a non-differentiated and proliferative state. J.Cell. Physiol. 2008, 214:354-362.
48. Trexler E.B., Bukauskas F.F., Kronengold J., Bargiello T.A., Verselis V.K. The first extracellular loop domain is a major determinant of charge selectivity in connexin46 channels. Biophys. J. 2000, 79:3036-3051.
49. Visvader J.E., Lindeman G.J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 2012, 10:717-728.
50. Wang H.Z., Veenstra R.D. Monovalent ion selectivity sequences of the rat connexin43 gap junction channel. J.Gen. Physiol. 1997, 109:491-507.
51. Wei C.J., Xu X., Lo C.W. Connexins and cell signaling in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20:811-838.
52. White T.W., Paul D.L. Genetic diseases and gene knockouts reveal diverse connexin functions. Annu. Rev. Physiol. 1999, 61:283-310.
53. Wong R.C., Pébay A. Study of gap junctions in human embryonic stem cells. Methods Mol. Biol. 2010, 584:211-228.
54. Yao J., Morioka T., Oite T. PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3-kinase in mesangial cells. Kidney Int. 2000, 57:1915-1926.
55. Yu S.C., Xiao H.L., Jiang X.F., Wang Q.L., Li Y., Yang X.J., Ping Y.F., Duan J.J., Jiang J.Y., Ye X.Z., et al. Connexin 43 reverses malignant phenotypes of glioma stem cells by modulating E-cadherin. Stem Cells 2012, 30:108-120.
56. Yulyana Y., Endaya B.B., Ng W.H., Guo C.M., Hui K.M., Lam P.Y., Ho I.A. Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma. Stem Cells Dev. 2013, 22:1870-1882.